Plamotamab
Plamotamab Basic information
- Product Name:
- Plamotamab
- Synonyms:
-
- Plamotamab
- Research Grade Plamotamab
- CAS:
- 2138442-31-4
- MW:
- 0
- Mol File:
- Mol File
Plamotamab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Plamotamab Usage And Synthesis
Uses
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds CD3 and CD20. Plamotamab recruits cytotoxic T cells to kill CD20+ expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo[1][2].
in vivo
Plamotamab (0.17 mg/kg; i.p.) causes tumor growth suppression in human PBMC-engrafted mouse model containing Raji xenograft[2].
Plamotamab (0.3 mg/kg; i.p.) leads to cytokine release in cynomolgus monkeys, indicating a safety to be improved[2].
References
[1] Parrondo RD, et al. Plamotamab (XmAb?13676) for Ibrutinib- refractory CXCR4-mutated extramedullary Waldenstr?m macroglobulinemia. Leuk Lymphoma. 2022 Mar;63(3):738-742. DOI:10.1080/10428194.2021.2005045
[2] Luo Peter PZ, et al. Anti-CD3 antibodies and methods of use thereof. World Intellectual Property Organization, WO2022170740 A1. 2022-08-18.
PlamotamabSupplier
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com